External quality assessment scheme for influenza antiviral susceptibility for the European Reference Laboratory Network for Human Influenza – 2015
In June and July 2015, an influenza virus antiviral susceptibility external quality assessment was held for European reference laboratories. This was the third antiviral EQA panel distributed by the European Reference Laboratory Network for Human Influenza since the European Influenza Surveillance Network was established in 2008. Overall results for the exercise were encouraging. Twenty-four laboratories from 19 European countries participated in the exercise while fourteen laboratories opted out because they did not perform assays capable of determining antiviral susceptibility. This represents increased capacity (24 laboratories) across the network, compared to the first EQA exercise in 2010 (20 laboratories).Phenotypic antiviral susceptibility results were encouraging. Eighteen of the 24 laboratories (75%) returned phenotypic results, with only nine incorrect results out of a total of 261 (3.4%).
HIV Pre-Exposure Prophylaxis in the EU/EEA and the UK: implementation, standards and monitoring
5 Mar 2021 - This operational guidance document provides practical recommendations and key considerations to inform the development and implementation of PrEP programmes at national and sub-national levels throughout the EU/EEA.
Sequencing of SARS-CoV-2 - first update
18 Jan 2021 - This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on which technologies to use and/or in deciding on the role of sequencing for SARS-CoV-2 diagnostics, research, outbreak investigations and surveillance.
External quality assessment (EQA) schemes to support European surveillance of Legionnaires’ disease 2019-2020 - EU/EEA countries
18 Dec 2020 - This report provides an analysis of the EQA performance of laboratories in the 28 EU/EEA countries in relation to the detection/isolation, identification, enumeration and quantification of Legionella spp. and the further characterisation of L. pneumophila, by serogrouping and sequence-based typing, from both clinical and environmental samples, where applicable.